Gf Fund Management Co. Ltd. Axsome Therapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,241 shares of AXSM stock, worth $139,351. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,241
Previous 1,018
21.91%
Holding current value
$139,351
Previous $86.1 Million
68.04%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AXSM
# of Institutions
360Shares Held
36.4MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$455 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$438 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$371 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$165 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$156 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.81B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...